Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS-Reference-Cited by-同舟云学术

Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS

Published:2017-09 Issue: Volume:124 Page:157-169
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Pasquarelli Noemi,Engelskirchen Michael,Hanselmann Johannes,Endres Sascha,Porazik Christoph,Bayer Hanna,Buck Eva,Karsak Meliha,Weydt Patrick^ORCID,Ferger Boris,Witting Anke

Funder

Boehringer Ingelheim Ulm University BioCenter (BIU) (Project N3)

International Graduate School in Molecular Medicine Ulm (IGradU)

Virtual Helmholtz Institute

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference66 articles.

1. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis;Acevedo-Arozena;Dis. Model Mech.,2011

2. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis;Apolloni;Dis. Model Mech.,2014

3. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice;Aso;J. Neurochem.,2008

4. The endocannabinoid system in amyotrophic lateral sclerosis;Bilsland;Curr. Pharm. Des.,2008

5. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice;Bilsland;FASEB J.,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis;European Journal of Neurology;2024-08-16

2. The Endocannabinoid System as a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis;Motor Neurons - New Insights;2024-06-19

3. Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization;Journal of Medicinal Chemistry;2024-01-19

4. Dysregulated expanded endocannabinoid system as therapeutic targets of amyotrophic lateral sclerosis;2024-01-15

5. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1G93A mouse model of amyotrophic lateral sclerosis;Neurobiology of Disease;2023-06